<DOC>
	<DOCNO>NCT02994173</DOCNO>
	<brief_summary>To study multimodal protocol combine adjunct ketamine oxycodone intravenous patient-controlled analgesia bolus dose effect patient scheduled posterolateral lumbar spine fusion bilateral transpedicular screw instrumentation</brief_summary>
	<brief_title>Dose-response Ketamine Patient Controlled Analgesia Orthopaedic Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>20 75 year age Scheduled elective posterolateral lumbar spine fusion bilateral transpedicular screw instrumentation general anaesthesia . Written informed consent participate patient A previous history intolerance study drug relate compound additive Concomitant drug therapy opioids strong CYP3A4 CYP2B6 inductor ( ) inhibitor ( ) 2 week prior study . Patients young 20 year old 75 year . BMI &gt; 35 , sleep apnoea , sleep disorder condition require treatment continuous positive airway pressure automatic positive airway pressure device . Existing significant liver kidney disease History ischemic heart disease conduction disturbance History alcoholism , drug abuse , psychological emotional problem likely invalidate inform consent Donation blood 4 week prior study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>